节律失常性心肌病的许多面孔:概述
Hanna J Tadros1, Christina Y Miyake1,2, Debra L Kearney3
1Department of Pediatrics, Section of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
The application of clinical genetics
|November 7, 2023
概括
节律失常性心肌病 (AC) 是一种影响心肌细胞的心肌疾病,导致心律失常. 这篇评论详细介绍了ACAC的细节.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 节律失调性心肌病 (AC) 的特征是心肌细胞的电机解.
- 在AC的组织学变化导致心律失常的临床特征.
- 交流可以影响右心室,两心室,或单独影响左心室.
研究的目的:
- 审查心律失调性心肌病的流行病学,病因,表现,评估和管理.
- 在整个时代连续性中详细介绍AC.
- 讨论不断变化的诊断标准和基因型-表型相关性.
主要方法:
- 关于心律失常性心肌病的最新数据的文献综述.
- 综合有关AC流行病学,病因学和临床表现的信息.
- 对诊断方式,标准和管理策略的分析.
主要成果:
- 对AC的理解已经进化,包括其可变心室参与.
- 对AC的诊断标准和方法一直在不断改进.
- 跨年龄组和基因型-表型联系的AC临床特征的知识已经得到了进展.
结论:
- 节律失调性心肌病是一种复杂的疾病,具有不断发展的诊断和管理范式.
- 对于有效的患者护理,跨年龄范围的全面了解至关重要.
- 对基因型-表型相关性的持续研究将完善AC诊断和治疗.
更多相关视频
相关概念视频
Cardiomyopathy I: Introduction and Classification
14
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Mechanism of Cardiac Arrhythmias
929
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
929
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Disturbances in Heart Rhythm
977
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
977
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11


